noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

Business and Economy > Industry News > Pharmaceuticals and Biotechnology

related tags Pharmaceutical Companies Animal Pharmaceutical Companies Drug Retailers and Distributors

Results Pharmaceuticals and Biotechnology

NACDS - National Association of Chain Drug Stores Inc.

Presidential Proclamation establishes a new tariff framework that differentiates between product types, countries of origin, and company-specific onshoring and pricing commitments.

-1m
HealthCare Institute of New Jersey

HealthCare Institute of New Jersey Statement on Today’s Announcement Concerning Section 232 Tariffs on Pharmaceuticals, Aluminum, Copper, and Steel

-22m
PhRMA - Pharmaceutical Research and Manufacturers of America

PhRMA Statement on Section 232 Tariff Announcement

-58m
Medicines Australia Ltd.

Medicines Australia firmly oppose US tariffs on pharmaceuticals

-9h 51m
FDA - Food and Drug Administration

RAW FARM (Raw milk cheddar cheese, shredded and block/Raw Farm) Recall reason: Potential Foodborne Illness – E. coli

-17h 6m
HealthCare Institute of New Jersey

Pulse 2026 Recap: Watch the Videos On‑Demand

-19h 9m
MHRA - Medicines and Healthcare products Regulatory Agency

UK and US deepen regulatory cooperation on medical devices, building on wider pharmaceutical partnership

-22h 29m
MHRA - Medicines and Healthcare products Regulatory Agency

NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA

-22h 53m
MHRA - Medicines and Healthcare products Regulatory Agency

Sevabertinib approved to treat adults with HER2-positive lung cancer that has spread or cannot be removed by surgery

yesterday
ABPI - The Association of the British Pharmaceutical Industry

The UK should seek to be a European leader for rare disease medicine, says new report

yesterday